Compare PLSE & REAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PLSE | REAL |
|---|---|---|
| Founded | 2014 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Other Specialty Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.7B |
| IPO Year | 2016 | 2019 |
| Metric | PLSE | REAL |
|---|---|---|
| Price | $14.81 | $16.43 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 8 |
| Target Price | ★ $22.00 | $15.71 |
| AVG Volume (30 Days) | 193.9K | ★ 2.5M |
| Earning Date | 11-05-2025 | 02-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $86,000.00 | ★ $662,789,000.00 |
| Revenue This Year | N/A | $17.10 |
| Revenue Next Year | $1,002.94 | $10.90 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 14.30 |
| 52 Week Low | $12.56 | $4.61 |
| 52 Week High | $25.00 | $16.74 |
| Indicator | PLSE | REAL |
|---|---|---|
| Relative Strength Index (RSI) | 55.43 | 66.53 |
| Support Level | $13.17 | $15.19 |
| Resistance Level | $14.91 | $16.74 |
| Average True Range (ATR) | 0.78 | 0.81 |
| MACD | 0.05 | -0.01 |
| Stochastic Oscillator | 59.50 | 88.18 |
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.
The RealReal is the largest pure-play luxury resale platform in the US, generating $1.8 billion in 2024 gross merchandise volume and addressing a niche (personal luxury resale) that had previously been serviced by inefficient upscale boutiques and local pawn shops. The company generates revenue via consignment and first-party sales on its online marketplace, and through a small volume of direct sales. With a hands-on approach that actively sources inventory and authenticates every item on its platform, The RealReal is able to justify much higher take rates than peers, working out to roughly 36% of net merchandise value in 2024, which excludes returns, cancellations, and first-party sales.